Latest Pefloxacin Stories
WHIPPANY, N.J., Nov. 24, 2014 /PRNewswire/ -- The U.S.
PINE BROOK, N.J., Sept. 22, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc.
Funding to Support Development of New Treatments for Drug-Resistant Gram-Negative Bacterial Infections OKLAHOMA CITY, Sept. 16, 2014 /PRNewswire/ -- Synereca Pharmaceutics, Inc.
A Group of 50 Adverse Drug Reaction Victims Rally in Washington, DC Before Meeting with Members of Congress; Thousands Connect Via Online Support Groups Emerging Worldwide WASHINGTON,
SAN DIEGO, May 8, 2014 /PRNewswire/ -- Otonomy, Inc., a biopharmaceutical company developing and commercializing innovative therapeutics for diseases and disorders of the inner and middle
Drug Allegedly Linked to Serious Muscle Problems and Nerve Damage Dallas, TX (PRWEB) February 20, 2014 The national law firm of
Over 400 subjects participating in phase 3 studies PINE BROOK, N.J., Feb. 5, 2014 /PRNewswire/ -- Elusys Therapeutics, Inc.
In contrast to findings of a recent study, researchers in Denmark did not find an association between use of a class of antibiotics known as fluoroquinolones (such as ciprofloxacin) and an increased risk of retinal detachment.
The United States Food and Drug Administration (FDA) has recently issued a Drug Safety Announcement and approved a Black Box Warning, one of the harshest warnings, for Pfizer’s antibiotic intravenous
Media health report cites problems with prescribing of antibiotics such as Zithromax by physicians.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.